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Initial + 16ml XOD +32 mL XOD
HA 0.8% MW 787 000 Da 621 450 Da 498 900 Da
Mannitol 3.5% + HA 0.8% MW 768 900 Da 717 750 Da 677 150 Da
1st 5th Change
SF volume (ml) 14.2 7.3 6.9 P < 0.05
HA (mg/ml) 1.50 1.72 0.22 P < 0.05
C4S (nmol/ml) 17.5 16.0 1.5 P < 0.05
C6s (nmol/ml) 59.7 50.2 9.5 P < 0.05
KS (mg/ml) 6.62 6.23 0.39 NS
IL-6 (pg/ml) 3733 457 3276 P < 0.05
Viscosity (mPa∙S) 49.6 72.5 22.9 P < 0.05
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S478cells expressed CD44, one receptor of hyaluronic acid (HA)(a main
component of synovial ﬂuid), the nanoparticles are recovered with HA
in order to enhance targeting of cells. Here, we have studied the
internalization kinetics of “empty” nanoparticles, and we have eval-
uated their neutrality on chondrocytes matrix synthesis, mesenchymal
stem cell (MSC) differentiation and inﬂammatory response. Innocuity
has been also evaluated in healthy animals, after direct intraarticular
injection of labelled nanoparticles (inﬂammatory response, Extrac-
ellular matrix integrity).
Methods: Articular cells (chondrocytes, synoviocytes) and MSC are
isolated from human donors, and cultured as primary culture. First, cells
are exposed with 100 mg/mL of NPs from 2 to 12 hours. At the end of the
kinetic immunoﬂuorescence pictures with DAPI (nuclear staining) are
realized to assess of the internalization of NPs, expression of inﬂam-
matory markers (IL1ß, TNFa and Cox2) are monitored by RT-qPCR
analysis, and conﬁrmed by PGE2 and nitrites measurement in
supernatant.
In other hand we evaluate, with pellets culture system, the effect of NPs
exposition on extracellular matrix synthesis by chondrocytes, with RT-
qPCR analysis of speciﬁc markers (Col2, Aggrecan and COMP), and by
histological study of pellets (Alcian blue staining of proteoglycans, Sirius
Red staining of collagen). Finally by growing MSC into 3 different dif-
ferentiation media, we investigate if NPs pre-treatment can interfere
with differentiation ability of MSC onto chondrogenic, adipogenic or
osteogenic pathway. RT-qPCR assays for differentiation markers
according to culture conditions and speciﬁc staining of lipid vesicles or
calcium deposits, allow us to conﬁrm the differentiation of cells.
Intraarticular injections were realized in healthy rat’s Knees. Structure
of joint (synovium, cartilage, subchondral bone) was assessed by his-
tological studies, performed at 7 and 10 days after injection (single and
repeated).
Results: For the different cell types, NPs are found into cytoplasm after
6 hours of exposition.
Internalization of these NPs leads to an increase of inﬂammatory
markers between 4 and 8 hours, basal level of expression being reached
after 12 hours. Even if there is a weak increase of PGE2 and nitrites
synthesis, that stay signiﬁcantly lower than with LPS stimulation, our
positive control of inﬂammation. NPs exposure, prior or after IL-1ß
stimulation, does not aggravate the inﬂammatory response of these
cells. When chondrocytes are exposed to NPs for 24 hours and then
cultured in pellets for 28 days, there is no difference in matrix synthesis
for the expression of mRNA and matrix deposition, as conﬁrmed with
histological exams. RT-qPCR and staining assays have also shown that
despite a pretreatment with NPs, MSCs can be conducted onto adipo-
genic, osteogenic or chondrogenic differentiation pathways. Histo-
logical analyses of extracellular matrix integrity and inﬂammatory
status do not demonstrate any differences for cartilage and subchondral
bone structures but reveal a weak hyperplasia of synovial membrane,
increasing with NPs concentration and the number of injection.
Conclusions: These NPs are rapidly internalized by human articular
cells, with only moderated and transient pro-inﬂammatory effects. In
addition there is no side effects on (1) ECM synthesis by chondrocytes
or MSC and (2) differentiation process due to the presence of NPs.
Labelled NPs with Cya3, once injected in joint of healthy rat, do not lead
to an inﬂammatory reaction and/or modiﬁcation of extracellular matrix
integrity. NPs are mainly found in synovium and repeated injections do
not generate severe adverse reaction. This drug delivery system can be
used to deliver an active molecule into the knee joint, thanks to the
absence of side effects.
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Purpose: Osteoarthritis(OA) is a degenerative joint disease associated
with harmful action of reactive oxygen species (ROS). ROS are involved
in the degradation of both aggrecan and high-molecular-weight hya-
luronan (HMW-HA). The later plays a key-role in the joint lubrication
and the visco-elastic and shock absorbing properties of the synovial
ﬂuid (SF). Viscosupplementation consists to inject intraarticularly
exogenous HMW-HA to restore the SF rheological properties, that aredramatically decreased in OA. However the injected HA is also rapidly
degradated by ROS, decreasing its effectiveness and duration of action.
The study objective was to evaluate the ability of Mannitol, a powerful
oxygen free radical scavenger, to reduce HMW-HA ROS mediated deg-
radation using a model of oxydative stress induced by xanthine (X) þ
xanthine oxidase (XOD). XOD is a ﬂavoprotein that catalyzes oxidation
of hypoxanthine to xanthine and then to uric acid generating high levels
of superoxide anion.
Methods: Hyaluronan (MW# 0.8mDa) was submitted to an oxidative
stress generated by the addition of X þ XOD. Then solution of the same
HA þ 35g/L of Mannitol in PBS buffer was studied. Different enzyme
concentrations were used and the HA properties were studied after 24
hours of contact at ambient temperature. Changes of the viscosity of the
solution were assessed by rheometry with a rheometer at 25 C using a
cone and plate geometry; steady-state viscosity was determined in Pa.s,
as a function of the shear rate. HA MW was also determined by steric
exclusion chromatography before and after oxydative stress.
Results: The presence of X/XOD degraded HA : 1) HA viscosity
decreased as a function of XOD concentration, 2) HA MW decreased
dramatically by 36.6%.On the opposite the presence of Mannitol stabi-
lized HA : 1) HA viscosity remained stable, 2) HA MW decreased only
slightly (-11.9%).
Conclusions: High concentrations (35g/L) of mannitol protect HA from
ROS-mediated degradation. These in vitro data suggest that mannitol
may increase the intra-articular residence time of HA and consequently
may improve efﬁcacy and/or effectiveness duration of viscosupple-
mentation.
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PATIENTS WITH KNEE OSTEOARTHRITIS
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Purpose: Intra-articular injection hyaluronic acid (HA) for the treat-
ment of patients with knee osteoarthritis (OA) has been commonly used
in Japan. However, American Academy of Orthopaedic Sugerons (AAOS)
announced intra-articular hyaluronic acid is no longer recommended in
the 2013 guideline. Efﬁcacy of the intra-articular HA still remain con-
troversial. We have performed ﬁve weekly HA injections according to
the Japanese insurance policy. Many biomarkers are reported: some
biomarkers reﬂects cartilage metabolism and the others reﬂects
inﬂammation reaction. We examined HA, chondroitin 4-sulfate (C4S),
chondroitin 6-sulfate (C6S), keratan sulfate (KS) for cartilage metabolic
biomarker and interleuikin-6 (IL-6) for inﬂammation biomarker. Il-6 is
well known as inﬂammation cytokine in the patients with rheumatoid
arthritis, but the change of Il-6 levels treated by the intra-articular HA in
the patients with OA has not been reported. The purpose of this study
was to investigate the change of the viscosity and biomarkers of
synovial ﬂuid and clinical symptoms before and after ﬁve weekly HA
injections.
Methods: Fifty seven patients (61 knees) with symptomatic knee OA
were enrolled between January 2010 and July 2013. We conducted 5
